Pape GR - Search Results

1

Precore mutant hepatitis B virus infection and liver disease.

Naoumov NV, Schneider R, Grötzinger T, Jung MC, Miska S, Pape GR, Will H. Naoumov NV, et al. Among authors: pape gr. Gastroenterology. 1992 Feb;102(2):538-43. doi: 10.1016/0016-5085(92)90101-4. Gastroenterology. 1992. PMID: 1732124

2

Immunology of hepatitis B infection.

Jung MC, Pape GR. Jung MC, et al. Among authors: pape gr. Lancet Infect Dis. 2002 Jan;2(1):43-50. doi: 10.1016/s1473-3099(01)00172-4. Lancet Infect Dis. 2002. PMID: 11892495 Review.

3

Heterogeneity of hepatitis B virus C-gene sequences: implications for amplification and sequencing.

Miska S, Günther S, Vassilev M, Meisel H, Pape G, Will H. Miska S, et al. J Hepatol. 1993 Apr;18(1):53-61. doi: 10.1016/s0168-8278(05)80009-1. J Hepatol. 1993. PMID: 8340610

4

Selection for a pre-C stop codon mutation in a hepatitis B virus variant with a pre-C initiation codon mutation during interferon treatment.

Santantonio T, Jung MC, Schneider R, Pastore G, Pape GR, Will H. Santantonio T, et al. Among authors: pape gr. J Hepatol. 1991 Nov;13(3):368-71. doi: 10.1016/0168-8278(91)90083-n. J Hepatol. 1991. PMID: 1725530

5

High prevalence and heterogeneity of HBV preC mutants in anti-HBe-positive carriers with chronic liver disease in southern Italy.

Santantonio T, Jung MC, Miska S, Pastore G, Pape GR, Will H. Santantonio T, et al. Among authors: pape gr. J Hepatol. 1991;13 Suppl 4:S78-81. doi: 10.1016/0168-8278(91)90030-f. J Hepatol. 1991. PMID: 1822518

6

Prevalence and type of pre-C HBV mutants in anti-HBe positive carriers with chronic liver disease in a highly endemic area.

Santantonio T, Jung MC, Miska S, Pastore G, Pape GR, Will H. Santantonio T, et al. Among authors: pape gr. Virology. 1991 Aug;183(2):840-4. doi: 10.1016/0042-6822(91)91022-9. Virology. 1991. PMID: 1853582

7

Immunogenicity of human hepatitis B virus P-gene derived proteins.

Weimer T, Weimer K, Tu ZX, Jung MC, Pape GR, Will H. Weimer T, et al. Among authors: pape gr. J Immunol. 1989 Dec 1;143(11):3750-6. J Immunol. 1989. PMID: 2584717

8

T cell recognition of hepatitis B and C viral antigens.

Jung MC, Diepolder HM, Pape GR. Jung MC, et al. Among authors: pape gr. Eur J Clin Invest. 1994 Oct;24(10):641-50. doi: 10.1111/j.1365-2362.1994.tb01055.x. Eur J Clin Invest. 1994. PMID: 7531642 Review.

9

Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection.

Jung MC, Diepolder HM, Spengler U, Wierenga EA, Zachoval R, Hoffmann RM, Eichenlaub D, Frösner G, Will H, Pape GR. Jung MC, et al. Among authors: pape gr. J Virol. 1995 Jun;69(6):3358-68. doi: 10.1128/JVI.69.6.3358-3368.1995. J Virol. 1995. PMID: 7538172 Free PMC article.

10

Long-term response to interferon therapy in chronic hepatitis B: importance of hepatitis B virus heterogeneity.

Santantonio T, Jung MC, Monno L, Milella M, Iacovazzi T, Pape GR, Pastore G, Will H. Santantonio T, et al. Among authors: pape gr. Arch Virol Suppl. 1993;8:171-8. doi: 10.1007/978-3-7091-9312-9_17. Arch Virol Suppl. 1993. PMID: 8260862 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page